Estimating the Human Papillomavirus Genotype Attribution in Screen-detected High-grade Cervical Lesions.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Estimating the Human Papillomavirus Genotype Attribution in Screen-detected High-grade Cervical Lesions.Published in
Epidemiology 2019; 30(4):590-6PMID
30985528ae974a485f413a2113503eed53cd6c53
10.1097/EDE.0000000000001026
Scopus Count
Collections
Related articles
- Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain.
- Authors: Perez S, Iñarrea A, Pérez-Tanoira R, Gil M, López-Díez E, Valenzuela O, Porto M, Alberte-Lista L, Peteiro-Cancelo MA, Treinta A, Carballo R, Reboredo MC, Alvarez-Argüelles ME, Purriños MJ
- Issue date: 2017 Nov 6
- Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
- Authors: Song F, Yan P, Huang X, Wang C, Du H, Qu X, Wu R
- Issue date: 2022 Jan 6
- Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study.
- Authors: Egli-Gany D, Spaar Zographos A, Diebold J, Masserey Spicher V, Frey Tirri B, Heusser R, Dillner J, Petignat P, Sahli R, Low N, CIN3+plus study group
- Issue date: 2019 Jan 30
- Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of three cohorts from randomized trials.
- Authors: Lehtinen M, Lagheden C, Luostarinen T, Eriksson T, Apter D, Harjula K, Kuortti M, Natunen K, Palmroth J, Petäjä T, Pukkala E, Siitari-Mattila M, Struyf F, Nieminen P, Paavonen J, Dubin G, Dillner J
- Issue date: 2017 Aug 18
- [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
- Authors: Luo HX, Du H, Liu ZH, Zhang LJ, Wang C, Wu RF
- Issue date: 2018 Mar 23